| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MGTX | Ordinary Shares | Sale | -$151K | -24K | -2.75% | $6.29 | 850K | Jan 21, 2025 | Direct | F1, F2, F3 |
| holding | MGTX | Ordinary Shares | 5.15K | Jan 21, 2025 | By Spouse | ||||||
| holding | MGTX | Ordinary Shares | 85K | Jan 21, 2025 | By Aigle Healthcare Partners III LLC |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2024. |
| F2 | The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $6.14 to $6.39, inclusive. |
| F3 | The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |